FDA.reportPublic FDA data

INTOMEDI FIRST AMPOULE EGF

Manufacturer
Janytree Inc.
Effective date
2022-07-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:50:09

Label at a glance#

ProductINTOMEDI FIRST AMPOULE EGF
Active ingredientADENOSINE
Label structure8 sections

Label contents#

Full prescribing information#

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Water, Ethyl Ascorbyl Ether, Dipropylene Glycol, Glycerin, 1,2-Hexanediol, Lactobacillus/Hydrolyzed
Pea Seed Extract Ferment Filtrate(Bio-Peptone®), Butylene Glycol, Dimethyl Sulfone, Centella Asiatica
Extract, Panthenol, Pentylene Glycol, Mentha Piperita (Peppermint) Extract, Hydrolyzed Collagen, Sodium
Hyaluronate, Allantoin, Polygonum Cuspidatum Root Extract, Scutellaria Baicalensis Root
Extract, Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Sodium Hyaluronate
Crosspolymer, Chamomilla Recutita (Matricaria) Flower Extract, Rosmarinus Officinalis (Rosemary) Leaf
Extract, Acetyl Hexapeptide-8(AHP-8), Copper Tripeptide-1(CTP-1), sh-Oligopeptide-1(EGF:1ppm)

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

adenosine

OTC - PURPOSE SECTION

An intensive skin energy ampoule for a younger, healthier-looking skin
Formulated with different growth factors and our patented Bio-Peptone®

WARNINGS

WARNINGS SECTION

For external use only When using this product
■ If following abnormal symptoms occurs after using the product, stop using the product and consult with a skin specialist. Symptoms : Red specks, swelling, itching
■ Do not use on the skin parts affected by wound, eczema, or dermatitis.
Keep out of reach of children.
■ If swallowed, get a medical help or contact a person in control center immediately.
■ Avoid contact with eyes.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

If swallowed, get a medical help or contact a person in control center immediately.

INDICATIONS & USAGE SECTION

apply a proper amount to the skin, and massage gently until fully absorbed

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
82879-0003-22025-01-30C16284748780-12cef2736-a33b-d83d-e063-dadaa90ab31fe3a67a76-3f19-3e13-e053-2995a90a4bbe

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82879-0003-1INTOMEDI FIRST AMPOULE EGF5 mL in 1 BOTTLELIQUID51
82879-0003-2INTOMEDI FIRST AMPOULE EGF5 in 1 PACKAGELIQUID51

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82879-0003INTOMEDI FIRST AMPOULE EGF (ADENOSINE) LIQUID [JANYTREE INC.]1Legacy NDC, 2 package rows20220714_e3a67a76-3f19-3e13-e053-2995a90a4bbe.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82879-000382879-0003-1, 82879-0003-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
BUTYLENE GLYCOL3XUS85K0RAIACT
WATER059QF0KO0RIACT
ADENOSINEK72T3FS567ACTIB
GLYCERINPDC6A3C0OXIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e3a67a76-3f1a-3e13-e053-2995a90a4bbee3a67a76-3f19-3e13-e053-2995a90a4bbe2022-07-12WarningsExact identifier
spl id: e3a67a76-3f1a-3e13-e053-2995a90a4bbe
spl set id: e3a67a76-3f19-3e13-e053-2995a90a4bbe

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.